Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Deacetylation of Chromatin and Gene Expression Regulation: A New Target for Epigenetic Therapy

Volume 20, Issue 1-2, 2015, pp. 1-17
DOI: 10.1615/CritRevOncog.2014012463
Get accessGet access

ABSTRACT

Besides the genetic information thath is encoded by DNA, heritable information can also be passed on without relying on changes in the nucleotide sequence of DNA, a phenomenon known as epigenetics. Gene expression in eukaryotes is partly regulated by epigenetic mechanisms both at the DNA and histone protein levels. Chromatin structure can be influenced by various modifications, including the reversible posttranslational processes of acetylation and deacetylation of DNA-binding proteins. Histone acetyl transferase (HAT) is referred to as the writer of this process, whereas histone deacetylase (HDAC) is the eraser of this lysine modification. Dysregulation of gene expression and changes in the HDAC expression profile have been associated with carcinogenesis, and HDAC inhibitors are already approved for the treatment of cutaneous T-cell lymphoma and peripheral T-cell lymphoma. These inhibitors are able to influence epigenetic processes by targeting HDAC activity, increasing nuclear histone acetylation status, and contributing to chromatin remodeling, thereby affecting gene expression. In addition, HDACs also act on a plethora of cytosolic proteins with many cellular functions, including angiogenesis, immune responses, and autophagy. In this review, we will give an overview of histone deacetylase and how it can regulate gene expression at the chromatin level.

CITED BY
  1. Vinken Mathieu, Regulation of connexin signaling by the epigenetic machinery, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1859, 2, 2016. Crossref

  2. Mileo Anna Maria, Miccadei Stefania, Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies, Oxidative Medicine and Cellular Longevity, 2016, 2016. Crossref

  3. Tao Hui, Shi Kai-Hu, Yang Jing-Jing, Li Jun, Epigenetic mechanisms in atrial fibrillation: New insights and future directions, Trends in Cardiovascular Medicine, 26, 4, 2016. Crossref

  4. Pillonel Vincent, Reichert Nina, Cao Chun, Heideman Marinus R., Yamaguchi Teppei, Matthias Gabriele, Tzankov Alexandar, Matthias Patrick, Histone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphoma, Scientific Reports, 6, 1, 2016. Crossref

  5. Camacho-Arroyo Ignacio, Hansberg-Pastor Valeria, Vázquez-Martínez Edgar Ricardo, Cerbón Marco, Mechanism of Progesterone Action in the Brain, in Hormones, Brain and Behavior, 2017. Crossref

  6. Olzscha Heidi, Bekheet Mina E., Sheikh Semira, La Thangue Nicholas B., HDAC Inhibitors, in Histone Deacetylases, 1436, 2016. Crossref

  7. Yen Ching-Yu, Huang Hurng-Wern, Shu Chih-Wen, Hou Ming-Feng, Yuan Shyng-Shiou F., Wang Hui-Ru, Chang Yung-Ting, Farooqi Ammad Ahmad, Tang Jen-Yang, Chang Hsueh-Wei, DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers, Cancer Letters, 373, 2, 2016. Crossref

  8. Barton Michelle C., Acidic shield puts a chink in p53's armour, Nature, 538, 7623, 2016. Crossref

  9. Di Paolo Antonello, Arrigoni Elena, Galimberti Sara, Danesi Romano, Pharmacogenetics and Personalized Medicine, in Drug Design: Principles and Applications, 2017. Crossref

  10. Shao Jinping, Cao Jing, Wang Jiannan, Ren Xiuhua, Su Songxue, Li Ming, Li Zhihua, Zhao Qingzan, Zang Weidong, MicroRNA-30b regulates expression of the sodium channel Nav1.7 in nerve injury-induced neuropathic pain in the rat, Molecular Pain, 12, 2016. Crossref

  11. Tsai Wen-Bin, Long Yan, Chang Jeffrey T., Savaraj Niramol, Feun Lynn G., Jung Manfred, Chen Helen H. W., Kuo Macus Tien, Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression, Scientific Reports, 7, 1, 2017. Crossref

  12. Abdel-Hafiz Hany, Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer, Diseases, 5, 3, 2017. Crossref

  13. Duan Lian, Liu Chao, Hu Junyuan, Liu Yongmei, Wang Jie, Chen Guang, Li Zhaoling, Chen Hengwen, Epigenetic mechanisms in coronary artery disease: The current state and prospects, Trends in Cardiovascular Medicine, 28, 5, 2018. Crossref

  14. Pasyukova Elena G., Vaiserman Alexander M., HDAC inhibitors: A new promising drug class in anti-aging research, Mechanisms of Ageing and Development, 166, 2017. Crossref

  15. Bachagol Deepa, Joseph Gilbert Stanley, Ellur Govindraj, Patel Kalpana, Aruna Pamisetty, Mittal Monika, China Shyamsundar Pal, Singh Ravendra Pratap, Sharan Kunal, Stimulation of liver IGF-1 expression promotes peak bone mass achievement in growing rats: a study with pomegranate seed oil, The Journal of Nutritional Biochemistry, 52, 2018. Crossref

  16. Roy Sambit, Gandra Divya, Seger Christina, Biswas Anindita, Kushnir Vitaly A, Gleicher Norbert, Kumar T Rajendra, Sen Aritro, Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells, Endocrinology, 159, 9, 2018. Crossref

  17. Olzscha Heidi, Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated, Biological Chemistry, 400, 7, 2019. Crossref

  18. Liu Yizhen, Huang Renhong, Liu Lianfang, Meng Yanchun, Liu Xiaojian, Epigenetic abnormalities of classical Hodgkin lymphoma and its effect on immune escape, Cell Biochemistry and Function, 38, 3, 2020. Crossref

  19. Shankar Eswar, Pandey Mitali, Verma Shiv, Abbas Ata, Candamo Mario, Kanwal Rajnee, Shukla Sanjeev, MacLennan Gregory T., Gupta Sanjay, Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer, Molecular Carcinogenesis, 59, 8, 2020. Crossref

  20. Kulka Linda Anna Michelle, Fangmann Pia-Victoria, Panfilova Diana, Olzscha Heidi, Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease, Frontiers in Cell and Developmental Biology, 8, 2020. Crossref

  21. Poria Dipak K., Sheshadri Namratha, Balamurugan Kuppusamy, Sharan Shikha, Sterneck Esta, The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression, Journal of Biological Chemistry, 296, 2021. Crossref

  22. Yadav Ekta, Yadav Pankajkumar, Kamal Mohammad A., Verma Amita, Polyphenols as Modulators of Oxidative Stress in Cancer Disease, in Polyphenols-based Nanotherapeutics for Cancer Management, 2021. Crossref

  23. Chen Jihui, Zhang Jian, Shaik Noor F., Yi Bing, Wei Xin, Yang Xiao-Feng, Naik Ulhas P., Summer Ross, Yan Guijun, Xu Xinyun, Sun Jianxin, The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase, Journal of Biological Chemistry, 294, 51, 2019. Crossref

  24. Forte Amalia, Galderisi Umberto, Cipollaro Marilena, De Feo Marisa, Corte Alessandro Della, Epigenetic regulation of TGF-β1 signalling in dilative aortopathy of the thoracic ascending aorta, Clinical Science, 130, 16, 2016. Crossref

  25. Okubo Kazuki, Miyai Kosuke, Kato Kimi, Asano Takako, Sato Akinori, Simvastatin-romidepsin combination kills bladder cancer cells synergistically, Translational Oncology, 14, 9, 2021. Crossref

  26. Ramírez-Farías Cynthia, González-Blas Daniel, Quintanar-Stephano Andrés, El papel del microambiente tumoral y los fibroblastos asociados a cáncer en el desarrollo y la progresión del cáncer de mama, Revista de Senología y Patología Mamaria, 2021. Crossref

  27. Dewi Citra, Fristiohady Adryan, Amalia Riezki, Khairul Ikram Nur Kusaira, Ibrahim Sugeng, Muchtaridi Muchtaridi, Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line, Molecules, 27, 12, 2022. Crossref

  28. Pinkerneil Maria, Hoffmann Michèle J., Deenen René, Köhrer Karl, Arent Tanja, Schulz Wolfgang A., Niegisch Günter, Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms, Molecular Cancer Therapeutics, 15, 2, 2016. Crossref

  29. Bora Vivek, Patel Dhwani, Johar Kaid, Goyal Ramesh K., Patel Bhoomika M., Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia, Canadian Journal of Physiology and Pharmacology, 100, 3, 2022. Crossref

  30. Sukocheva Olga A., Lukina Elena, Friedemann Markus, Menschikowski Mario, Hagelgans Albert, Aliev Gjumrakch, The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives, Seminars in Cancer Biology, 82, 2022. Crossref

  31. Garmpis Nikolaos, Damaskos Christos, Dimitroulis Dimitrios, Kouraklis Gregory, Garmpi Anna, Sarantis Panagiotis, Koustas Evangelos, Patsouras Alexandros, Psilopatis Iason, Antoniou Efstathios A., Karamouzis Michail V., Kontzoglou Konstantinos, Nonni Afroditi, Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer, Journal of Personalized Medicine, 12, 10, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain